Cara Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cara Therapeutics, Inc.
CIK #0001346830
EDGAR Form CIK 2011 - 2026
10-K [0001346830]
10-Q [0001346830]
3 [0001346830]
4 [0001346830]
8-K [0001346830]
D [0001346830]
SC 13D [0001346830]
SC 13G [0001346830]
Form 13D/13G Filer Form 13D/13G Subject Filed
Slate Path Capital LP Tvardi Therapeutics Inc [2025-08-14]
Sporos BioVentures LLC Tvardi Therapeutics Inc [2025-08-08]
Depinho Ronald A Tvardi Therapeutics Inc [2025-06-02]
Tweardy Samuel David Tvardi Therapeutics Inc [2025-05-02]
Tweardy David John Tvardi Therapeutics Inc [2025-05-02]
Solas Tvardi Sidecar LLC Tvardi Therapeutics Inc [2025-04-22]
Vifor International Ltd Cara Therapeutics Inc [2024-10-30]
Bain Capital Life Sciences Opportunities III LP Cara Therapeutics Inc [2022-11-18]
Vanguard Group Inc Cara Therapeutics Inc [2022-02-09]
First Manhattan Co Cara Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
Wyzga Michael S
Tvardi Therapeutics, Inc.
Hall Wallace L Jr
Shiff Susan Ph.D.
Smith Cynthia
Shah Sujal
Alibhai Imran Nizamudin
Conn Avi Daniel
O'Brien Stephen Paul
Kauh John Saewook M.D.
View All
Terms | Privacy | Guide
tony@aum13f.com